Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Haemophilus influenza type b PRP 20g/mL conjugated to C. Diphtheria CRM protein 50g/mL Injection, solution Lederle Laboratories Division, American Cyanamid Co., Pearl River, New York, United States of America; and Abbott Laboratories, McPherson, Kansas, United States of America HibTITER Haemophilus influenza type b PRP 20g/mL conjugated to C. Diphtheria CRM protein 50g/mL, adsorbed tetanus vaccine 10LfU/mL, diphtheria toxoid 25LfU/mL, pertussis vaccine 32IOU/mL Injection, solution Lederle Laboratories Division, American Cyanamid Co., Pearl River, New York, United States of America Tetramune Penciclovir 1% w/w Cream, topical SmithKline Beecham Pharmaceuticals, Magpie Wood, Manor Royal, Crawley, Sussex, England; and SmithKline Beecham Liquides Industries, Herouville, St. Clair, France Vectavir Dated this 30th day of April 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.